OmniComm Penetrates Growing Israeli Life Sciences Market
TrialMaster® EDC selected by leading Israeli data management and biostatistics firm
Fort Lauderdale, FL, April 11, 2016 - OmniComm Systems, Inc., a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm’s TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations. “We are pleased that OmniComm Systems is realizing the value of the Israeli market and the position of Medistat as a global provider of data management and biostatistician solutions,” said Dr. Gil Harari President and CEO of Medistat, “We truly believe that the cooperation with OmniComm will be a key factor to becoming a leader in the rapidly growing Intelligent EDC market in Israel and worldwide.”
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
